Jagannath Sahoo

Jagannath Sahoo

Auto-generated profile, based on publicly available information

Jagannath Sahoo

Shobhaben Pratapbhai Patel, School of Pharmacy & Technology Management, SVKM's Narsee Monjee Institute of Management Studies (NMIMS), Deemed-to-be University, V.L. Mehta Road, Vile Parle (W), Mumbai, 400 056, Maharashtra, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2025 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
AVArjvee Vaidya
Arjvee Vaidya
JSJagannath Sahoo
Jagannath Sahoo
PSPravin K. Shende
Pravin K. Shende


5 July 2024 in Journal of Computational Biophysics and Chemistry
Verified
Journal Article
Closed access
RTRitu Tomar
Ritu Tomar
SMShashank Shekher Mishra
Shashank Shekher Mishra
JSJagannath Sahoo
Jagannath Sahoo
SRSANTOSH KUMAR RATH
SANTOSH KUMAR RATH

1 October 2021 in Current Drug Therapy
Verified
Journal Article
Closed access
PDF file
DTDevika Tripathi
Devika Tripathi
NCNandini Chaudhary
Nandini Chaudhary
DSDinesh Kumar Sharma
Dinesh Kumar Sharma
JSJagannath Sahoo
Jagannath Sahoo
Background: Executing the centralization of medication in the foundational flow for approaching their pharmacological has necessitated studying a vital parameter, i.e. solubility reaction. The poor water dissolvability has an impact on medication adequacy and, consequently, owned poor drugs bioavailability. Aim: The aim of this study is to attain the convergence of medication in an introductory course, a significant parameter, i.e. solvency, has been executed for the pharmacological reactions. On account of revolution and advancement, there is a diversity of new medications, and their subordinates are approachable. Over 40% of lipophilic medication up-and-comers neglect to achieve because of poor bioavailability even though these medications have potential pharmacodynamics activities. Due to high market requirements, lipophilic medication has accomplished the relevant pharmacological activity. Consequently, most strategies are streamlined to improve fluid solvency to upgrade proficiency and lessen the reactions for specific medications. Objectives: The process of hydrotropic solubilization has persisted a novel and promising methodology to improve the solvency of drugs with poor water solvency by ascending the dissolvability to many folds with the involvement of hydrotropes, i.e. Niacinamide, Urea, sodium benzoate, sodium citrate, and so on. The potentiality of hydrotropic solubilization counts on the balance among hydrophobic and hydrophilic parts of hydrotropes. Hence, advancement in hydrotropic updated visualized in novel drug delivery systems and their mechanism of compatibilities and biocompatibilities. Novelty is also reprinted in its usefulness as an extraction agent for bio-active compounds to increase the rate of heterogeneous reactions and in a green synthesis for a substrate. Conclusion: This review focuses on practice utilized for solubility management of drugs with poor solvency, its unmet needs, utilizing the artificial machine learning in the prediction of hydrotropeenhanced solubilization of drugs, practical applicability in drug delivery, interpreted kinetic involved, and various associated mechanisms.

30 September 2021 in Saudi Journal of Biological Sciences
Verified
Journal Article
Open access
MAMANDEEP KUMAR ARORA
MANDEEP KUMAR ARORA
PGParul Grover
Parul Grover
SASyed Mohammed Basheeruddin Asdaq
Syed Mohammed Basheeruddin Asdaq
LMLovekesh Mehta
Lovekesh Mehta
RTRitu Tomar
Ritu Tomar
MAMajid Alhomrani
Majid Alhomrani
Coronavirus 2019 (COVID-19) is caused by ‘severe acute respiratory syndrome coronavirus 2′ (SARS-CoV-2), first reported in Wuhan, China in December 2019, which eventually became a global disaster. Various key mediators have been reported in the pathogenesis of COVID-19. However, no effective pharmacological intervention has been available to combat COVID-19 complications. The present study screens nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) as potential inhibitors of this present generation coronavirus infection using an in-silico approach. The SARS-CoV-2 proteins (nucleocapsid, proteases, post-fusion core, phosphatase, endoriboruclease) and ACE-2 protein were selected. The 2D structure of nicotinamide ribonucleoside and nicotinamide ribonucleotide was drawn using ChemDraw 14.0 and saved in .cdx format. The results were analyzed using two parameters: full fitness energy and binding free energy (ΔG). The full fitness energy and estimated ΔG values from docking of NM, and NMN with selected SARS-CoV-2 target proteins, ADMET prediction and Target prediction indicate the interaction of NR and NMN in the treatment of COVID-19. Based on full fitness energy and estimated ΔG values from docking studies of NM and NAM with selected SARS-CoV-2 target proteins, ADME prediction, target prediction and toxicity prediction, we expect a possible therapeutic efficacy of NR in the treatment of COVID-19.

13 May 2021 in Asian Journal of Pharmaceutical and Clinical Research
Verified
Journal Article
Open access
PDF file
DTDevika Tripathi
Devika Tripathi
DSDinesh Kumar Sharma
Dinesh Kumar Sharma
JSJagannath Sahoo
Jagannath Sahoo
Objectives: Mefenamic acid is used as a modal nonsteroidal anti-inflammatory drug for analytical estimation. Due to the poor aqueous solubility, mefenamic acid liberated reduced bioavailability. Methods: The hydrotropic solubilization technique is a promising technique used to improve the solubility of water-insoluble drugs. Experimentally, 2 M sodium benzoate has been employed in the prior titrimetric estimation of mefenamic acid and shows synergistic enhancement in the solubility of mefenamic acid by many folds as compared to the distilled water. Similarly, sodium benzoate approach was further applied in analytical estimation of marketed oral dosage forms in tablets, capsules, and suspension for checking the reproducibility of applied approach by ultraviolet (UV) method. Validation of UV method was further done and checked for linearity, accuracy, and precision. Drug degradation studies were also performed successfully to investigate the sustainability of mefenamic acid in various dosage forms under various stress conditions and to establish the preferred storage conditions for the drug. Results: In the present experimental investigation, obtained mean % recoveries were close to 100 indicating the accuracy of the proposed approach. Similarly, in analytical estimation of mefenamic acid in oral marketed forms, results have reported lower values of standard deviation, % coefficient of variation, and standard error facilitated the reproducibility and precision of the proposed approach in the titrimetric estimation and analytical validation of UV method mefenamic acid in bulk and marketed forms. Conclusion: Therefore, a new, simple, precise, and inexpensive proposed method was executed by validating the result statistically.